SSA
MGNX icon

Schonfeld Strategic Advisors’s MacroGenics MGNX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-39,917
Closed -$115K – 2847
2026
Q1 		$115K Buy
+39,917
New +$85.1K ﹤0.01% 1861
2025
Q1 		– Sell
-857,505
Closed -$2.79M – 2383
2024
Q4 		$2.79M Buy
+857,505
New +$3.09M 0.02% 708
2024
Q3 		– Sell
-122,782
Closed -$522K – 2259
2024
Q2 		$522K Buy
+122,782
New +$1.2M ﹤0.01% 1464
2024
Q1 		– Sell
-76,246
Closed -$733K – 2274
2023
Q4 		$733K Buy
+76,246
New +$527K ﹤0.01% 1149
2022
Q4 		– Sell
-62,600
Closed -$216K – 2852
2022
Q3 		$216K Sell
62,600
-46,800
-43% -$179K ﹤0.01% 2293
2022
Q2 		$323K Buy
+109,400
New +$575K ﹤0.01% 1627

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Schonfeld Strategic Advisors's MGNX Position: Q2 2026 in Review

Schonfeld Strategic Advisors sold out of MacroGenics (MGNX) in Q2 2026, closing a stake of 39,917 shares — an estimated $115K sold.

Schonfeld Strategic Advisors first reported a position in MGNX in Q2 2022 and held it in 6 quarters. The position peaked at $2.79M in Q4 2024. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Schonfeld Strategic Advisors reported no remaining MacroGenics position as of Q2 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 39,917 MacroGenics shares in Q2 2026, an estimated $115K.
  • Schonfeld Strategic Advisors first reported a position in MacroGenics in Q2 2022 and held it in 6 quarters.
  • Schonfeld Strategic Advisors's MacroGenics position peaked at $2.79M in Q4 2024.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.